Log in to save to my catalogue

Multi-Omics Approach for Studying Tears in Treatment-Naïve Glaucoma Patients

Multi-Omics Approach for Studying Tears in Treatment-Naïve Glaucoma Patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6721157

Multi-Omics Approach for Studying Tears in Treatment-Naïve Glaucoma Patients

About this item

Full title

Multi-Omics Approach for Studying Tears in Treatment-Naïve Glaucoma Patients

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2019-08, Vol.20 (16), p.4029

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Primary open-angle glaucoma (POAG) represents the leading cause of irreversible blindness worldwide and is a multifactorial, chronic neurodegenerative disease characterized by retinal ganglion cell and visual field loss. There are many factors that are associated with the risk of developing POAG, with increased intraocular pressure being one of the...

Alternative Titles

Full title

Multi-Omics Approach for Studying Tears in Treatment-Naïve Glaucoma Patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6721157

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6721157

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms20164029

How to access this item